239 Efficacy and toxicity of single agent immune checkpoint inhibitors among adults with cancer aged ≥80 years: a multicenter international cohort study
Publication
, Conference
Nebhan, C; Cortellini, A; Ma, W; Ganta, T; Song, H; Ye, F; Irlmeier, R; Debnath, N; Saeed, A; Radford, M; Alahmadi, A; Diamond, A; Hoimes, C ...
Published in: Journal for ImmunoTherapy of Cancer
November 2021
Duke Scholars
Published In
Journal for ImmunoTherapy of Cancer
DOI
EISSN
2051-1426
Publication Date
November 2021
Volume
9
Issue
Suppl 2
Start / End Page
A257 / A257
Publisher
BMJ
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3204 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Nebhan, C., Cortellini, A., Ma, W., Ganta, T., Song, H., Ye, F., … Naqash, A. R. (2021). 239 Efficacy and toxicity of single agent immune checkpoint inhibitors among adults with cancer aged ≥80 years: a multicenter international cohort study. In Journal for ImmunoTherapy of Cancer (Vol. 9, pp. A257–A257). BMJ. https://doi.org/10.1136/jitc-2021-sitc2021.239
Nebhan, Caroline, Alessio Cortellini, Weijie Ma, Teja Ganta, Haocan Song, Fei Ye, Rebecca Irlmeier, et al. “239 Efficacy and toxicity of single agent immune checkpoint inhibitors among adults with cancer aged ≥80 years: a multicenter international cohort study.” In Journal for ImmunoTherapy of Cancer, 9:A257–A257. BMJ, 2021. https://doi.org/10.1136/jitc-2021-sitc2021.239.
Nebhan C, Cortellini A, Ma W, Ganta T, Song H, Ye F, et al. 239 Efficacy and toxicity of single agent immune checkpoint inhibitors among adults with cancer aged ≥80 years: a multicenter international cohort study. In: Journal for ImmunoTherapy of Cancer. BMJ; 2021. p. A257–A257.
Nebhan, Caroline, et al. “239 Efficacy and toxicity of single agent immune checkpoint inhibitors among adults with cancer aged ≥80 years: a multicenter international cohort study.” Journal for ImmunoTherapy of Cancer, vol. 9, no. Suppl 2, BMJ, 2021, pp. A257–A257. Crossref, doi:10.1136/jitc-2021-sitc2021.239.
Nebhan C, Cortellini A, Ma W, Ganta T, Song H, Ye F, Irlmeier R, Debnath N, Saeed A, Radford M, Alahmadi A, Diamond A, Hoimes C, Ramaiya N, Presley C, Owen D, Alaiwi SA, Nassar A, Ricciuti B, Lamberti G, Bersanelli M, Casartelli C, Buti S, Marchetti P, Giusti R, Filetti M, Vanella V, Mallardo D, Macherla S, Sussman T, Botticelli A, Galetta D, Catino A, Pizzutilo P, Genova C, Bello MGD, Kalofonou F, Daniels E, Ascierto P, Pinato D, Choueiri T, Johnson D, Marron T, Wang Y, Naqash AR. 239 Efficacy and toxicity of single agent immune checkpoint inhibitors among adults with cancer aged ≥80 years: a multicenter international cohort study. Journal for ImmunoTherapy of Cancer. BMJ; 2021. p. A257–A257.
Published In
Journal for ImmunoTherapy of Cancer
DOI
EISSN
2051-1426
Publication Date
November 2021
Volume
9
Issue
Suppl 2
Start / End Page
A257 / A257
Publisher
BMJ
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3204 Immunology